Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 320

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Cytokines: abnormalities in major depression and implications for pharmacological treatment

O'Brien, Sinead M., Scott, Lucinda V., Dinan, Timothy G.·2004·Human Psychopharmacology: Clinical and Experimental

Abstract

The role of cytokines in depression was first considered when the cytokine interferon resulted in ‘sickness behaviour’, the symptoms of which are similar to those of major depression. The latter is associated with an increase in pro‐inflammatory cytokines such as interleukin‐1 (IL‐1), interleukin‐6 (IL‐6) and tumour necrosis factor alpha (TNF‐α). These cytokines are potent modulators of corticotropin‐releasing hormone (CRH) which produces heightened hypothalamic–pituitary–adrenal axis (HPA) activity characterized by increases in ACTH and cortisol, both of which are reported elevated in major depression. Antidepressant treatment has immunomodulatory effects with increases in the production of IL‐10, which is an anti‐inflammatory cytokine. This review based on a Medline search from 1980–2003, focuses on the evidence available of cytokine changes in acute stress, chronic stress and major depression. It examines the effects of antidepressant treatment on immune parameters in both animal models and clinical trials. We suggest that future antidepressants may target the immune system by either blocking the actions of pro‐inflammatory cytokines or increasing the production of anti‐inflammatory cytokines. Copyright © 2004 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hup.609

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 320

Metadata

Authors
O'Brien, S. M., Scott, L. V., & Dinan, T. G.
Venue
Human Psychopharmacology: Clinical and Experimental
Publisher
Wiley
Published
2004-07-06
Volume
19
Issue
6
Pages
397-403
ISSN
  • 0885-6222 (ISSN-L)
  • 1099-1077
OpenAlex
W1984760175
Cited by
320
References
66
FWCI
7.98
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.